Fed Circuit rejects Cellect rehearing on double patenting

En banc petition concerning obviousness-type double-patenting rejected by the Court of Appeals | Decision on patent term adjustment has been closely followed by pharma companies, NYIPLA, and AIPLA.

Related Keywords

Perry Shutterstock , ,Fed Circuit ,Fus Court Of Appeals For The Federal Circuit ,Patent Trial And Appeal Board ,Us Patent And Trademark Office ,Ellect ,Samsung ,Bviousness Type ,